Ronald Dotson

Protective Effects of CGS 30440, a Combined Angiotensin-Converting Enzyme Inhibitor and Neutral Endopeptidase Inhibitor, in a Model of Chronic Renal Failure

David S. Cohen, Janice Mathis, Ronald Dotson et al. · Journal of Cardiovascular Pharmacology · 1998 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +9

Synthesis and diuretic profile of 3-(3-amino-1,2,4-oxadiazol-5-yl)-5-chloro-2,6-pyrazinediamine, an amiloride-type diuretic

Jeffrey W. H. Watthey, Mahesh Desai, Richard Rutledge et al. · Journal of Medicinal Chemistry · 1980 · 26 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models

Edmond C. Ku, A. Raychaudhuri, Geetha Ghai et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1988 · 25 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 4. 8-[[(4-Chlorophenyl)sulfonyl]amino]-4-[3-(3-pyridinyl)propyl]octanoic acid and analogs

Shripad S. Bhagwat, Candido Gude, Clay Boswell et al. · Journal of Medicinal Chemistry · 1992 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Synthesis and biological activity of phenoxyphenyl oxamic acid derivatives related to l-thyronine

James L. Stanton, Edna Cahill, Ronald Dotson et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 19 citations

Natural Sciences, Chemistry, Pharmacology +11